Abstract:Objective: To assess the utility and effectiveness of targeted capture and massively parallel sequencing technology in atypical leukoencephalopathy patients Background: Leukoencephalopathy is a disease with high clinical heterogeneity and involving in multiple genes, the etiological diagnosis of atypical leukoencephalopathy is difficult even for experienced neurologists. To help these patients make clear diagnosis, our team designed the personalized chip which contains 118 genes reported to be associated with leukoencephalopathy. Design/Methods: We performed a retrospective study. From December 2013 to June 2015, 48 patients with atypical leukoencephalopathy were recruited into our cohort according to the strict inclusion and exclusion criteria, at the same time, detail clinical and head imaging data were recorded. Then we screened for these patients using the personalized chip and made the validation among their parents using Sanger sequencing. Results: A total of 39.6[percnt] (19/48) of the patients exhibited pathogenic mutations. Including four associated with metachromatic leukodystrophy, three associated with vanishing white matter leukoencephalopathy, three associated with mitochondrial complex enzyme I deficiency, one associated with Krabbe disease, two associated with megalencephalic leukoencephalopathy with subcortical cysts, two associated with Pelizaeus-Merzbacher disease, one associated with X-linked adrenoleukodystrophy, one associated with Zegwell syndrome, one associated with amyotrophic lateral sclerosis and one associated with Alexander disease. In this study, fifteen pathogenic mutation sites were identified for the first time. Conclusions: These data supported the combination of targeted capture and massively parallel sequencing technology with clinical and genetic diagnosis, allowing the identification of atypical leukoencephalopathy, highlighting its usefulness for rapid and comprehensive genetic testing in the clinical. Our study reflects the incidence of leukoencephalopathy in south China, it also expand our knowledge of the genetic and clinical spectra of leukoencephalopathy. Study Supported by: NSFC :81371434, 81171226; Science and technology plan of Hunan province: 2011FJ3163 and MyGenostics Inc. Disclosure: Dr. Wang has nothing to disclose. Dr. Yin has nothing to disclose. Dr. Wu has nothing to disclose. Dr. Yang has nothing to disclose. Dr. He has nothing to disclose. Dr. Peng has nothing to disclose.

“Genotype-First” Approaches on a Curious Case of Idiopathic Progressive Cognitive Decline

Diagnostic and Clinical Utility of Whole Genome Sequencing in a Cohort of Undiagnosed Chinese Families with Rare Diseases

Using Next-Generation Sequencing As A Genetic Diagnostic Tool in Rare Autosomal Recessive Neurologic Mendelian Disorders

Identification of 11 Potentially Relevant Gene Mutations Involved in Growth Retardation, Intellectual Disability, Joint Contracture, and Hepatopathy

Compound Heterozygous Mutations in the Neuraminidase 1 Gene in Type 1 Sialidosis: A Case Report and Review of Literature

(CAG)n loci as genetic modifiers of age-at-onset in patients with Machado-Joseph disease from mainland China.

Targeted next generation sequencing in 112 Chinese patients with intellectual disability/developmental delay: novel mutations and candidate gene

Exome Sequencing and Gene Prioritization Correct Misdiagnosis in a Chinese Kindred with Familial Amyloid Polyneuropathy

Clinical and Genetic Characteristics and Prenatal Diagnosis of Rare Monogenic Global Developmental Delay and Intellectual Disability.

Familial SYN1 Pathogenic Mutations Related Neurodevelopmental Disorders in Asian Pediatric Patients

Targeted Capture and Massively Parallel Sequencing to Identify Atypical Leukoencephalopathy in 48 Chinese Patients (P3.265)

Targeted Capture and Massively Parallel Sequencing to Identify Atypical Leukoencephalopathy in 48 Chinese Patients (I7.011)

Identification of two novel variants in ALG11 causing congenital disorder of glycosylation

Clinical and Genetic Characteristics and Prenatal Diagnosis of Patients Presented GDD/ID with Rare Monogenic Causes

Resolution of SLC6A1 variable expressivity in a multi-generational family using deep clinical phenotyping and Drosophila models

Identification and characterization of novel genetic variants in the first Chinese family of mucopolysaccharidosis IIIC (Sanfilippo C syndrome)

Molecular Defects Identified by Whole Exome Sequencing in a Child with Atypical Mucopolysaccharidosis IIIB

[Clinical and Genetic Analysis of a Family with Aicardi-Goutières Syndrome and Literature Review].

Compound Heterozygous Mutation of the SNX14 Gene Causes Autosomal Recessive Spinocerebellar Ataxia 20

Clinical Features of Chinese Patients with Gerstmann–Sträussler–Scheinker Identified by Targeted Next-Generation Sequencing

The G41D mutation in SOD1-related amyotrophic lateral sclerosis exhibits phenotypic heterogeneity among individuals: A case report and literature review